Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NCT ID: NCT03677739
Last Updated: 2025-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
1160 participants
INTERVENTIONAL
2019-06-03
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
NCT03028948
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
NCT03725449
Melanoma Risk Assessment & Tailored Intervention
NCT01356771
Tailored Intervention for Melanoma Patient's Families
NCT00816374
Targeted Intervention for Melanoma Prevention
NCT00394134
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To examine the efficacy of the Young Melanoma Family Facebook intervention versus the Healthy Lifestyle Facebook intervention on total cutaneous exam (primary outcome), skin self-exam frequency and comprehensiveness, and sun protection practices (secondary outcomes) of first degree relatives (FDRs) of young melanoma survivors.
SECONDARY OBJECTIVES:
I. To examine the efficacy of the Young Melanoma Family Facebook intervention on patients? skin self-exam frequency and comprehensiveness and sun protection habits.
II. To examine the mechanisms of intervention efficacy.
OUTLINE:
PHASE I: Researchers refine content for the Facebook intervention condition and conduct usability testing.
PHASE II: Participants are randomized to 1 of 2 arms.
ARM I: Participants join a secret Young Melanoma Family Facebook Group and view post messages focusing on skin cancer for 12 weeks.
ARM II: Participants join a secret Healthy Lifestyle Facebook Group and view post messages focusing on healthy lifestyle for 12 weeks.
PHASE III: Dissemination planning.
After completion of study, participants are followed up at 6 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1 Young melanoma Family Facebook focusing on skin cancer
Participants join a secret Young melanoma Family Facebook Group and view post messages focusing on skin cancer for 12 weeks.
Informational Intervention
Receive information focusing on skin cancer
Survey Administration
Ancillary studies
Arm 2 Healthy Lifestyle Facebook focusing on healthy lifestyle
Participants join a secret Healthy Lifestyle Facebook Group and view post messages focusing on healthy lifestyle for 12 weeks.
Informational Intervention
Receive information on healthy lifestyle
Survey Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Informational Intervention
Receive information focusing on skin cancer
Informational Intervention
Receive information on healthy lifestyle
Survey Administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PATIENT: Age at diagnosis 18-39 years
* PATIENT: Completed treatment at least 3 months previously
* PATIENT: Recruited from New Jersey or California State Cancer Registry or MD Anderson Cancer Center
* PATIENT: Does not have a concurrent cancer diagnosis
* PATIENT: Able to speak and read English
* PATIENT: Access to computer, internet, and has a Facebook account
* PATIENT: At least one family member consents
* FDR: Current age 18-80 years
* FDR: Does not have a personal history of melanoma
* FDR: Able to speak and read English
* FDR: Access to computer, internet, and has a Facebook account
* FDR: Has only one FDR with melanoma (patient)
* FDR: Has not had a total cutaneous examination (TCE) in the past 3 years, has done skin self-exam (SSE) fewer than three times in the past year, OR has a sun protection habits average score less than or equal to 4 (?often?)
* FDR: Patient consents
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sharon Manne, PhD
Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon Manne
Role: PRINCIPAL_INVESTIGATOR
Rutgers Cancer Institute of New Jersey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Manne S, Pagoto S, Peterson S, Heckman C, Kashy D, Berger A, Studts C, Negron R, Buller D, Paddock L, Gallo J, Kulik A, Frederick S, Pesanelli M, Domider M, Grosso M. Facebook Intervention for Young-Onset Melanoma Survivors and Families: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Jan 24;12:e39640. doi: 10.2196/39640.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2018-01741
Identifier Type: REGISTRY
Identifier Source: secondary_id
Pro2018001697
Identifier Type: -
Identifier Source: secondary_id
131812
Identifier Type: OTHER
Identifier Source: secondary_id
Pro2018001697
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.